Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0011759 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Wenqiao He und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, No…. Hauptthemen laut MEDLINE: Plasmodium ovale, Malaria, Real-Time Polymerase Chain Reaction, Sensitivity and Specificity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, US National Institutes of Health, Global Fund to Fight AIDS, Tuberculosis and Malaria.
Abstract (Originalsprache)
Background
The parasite species Plasmodium ovalecurtisi (P. ovalecurtisi) and Plasmodium ovalewallikeri (P. ovalewallikeri), formerly known as Plasmodium ovale, are endemic across multiple African countries. These species are thought to differ in clinical symptomatology and latency, but only a small number of existing diagnostic assays can detect and distinguish them. In this study, we sought to develop new assays for the detection and differentiation of P . ovalecurtisi and P . ovalewallikeri by leveraging recently published whole-genome sequences for both species.
Methods
Repetitive sequence motifs were identified in available P . ovalecurtisi and P . ovalewallikeri genomes and used for assay development and validation. We evaluated the analytical sensitivity of the best-performing singleplex and duplex assays using synthetic plasmids. We then evaluated the specificity of the duplex assay using a panel of samples from Tanzania and the Democratic Republic of the Congo (DRC), and validated its performance using 55 P . ovale samples and 40 non-ovale Plasmodium samples from the DRC.
Results
The best-performing P . ovalecurtisi and P . ovalewallikeri targets had 9 and 8 copies within the reference genomes, respectively. The P . ovalecurtisi assay had high sensitivity with a 95% confidence lower limit of detection (LOD) of 3.6 parasite genome equivalents/μl, while the P . ovalewallikeri assay had a 95% confidence LOD of 25.9 parasite genome equivalents/μl. A duplex assay targeting both species had 100% specificity and 95% confidence LOD of 4.2 and 41.2 parasite genome equivalents/μl for P . ovalecurtisi and P . ovalewallikeri , respectively.
Conclusions
We identified promising multi-copy targets for molecular detection and differentiation of P . ovalecurtisi and P . ovalewallikeri and used them to develop real-time PCR assays. The best performing P . ovalecurtisi assay performed well in singleplex and duplex formats, while the P . ovalewallikeri assay did not reliably detect low-density infections in either format. These assays have potential use for high-throughput identification of P . ovalecurtisi , or for identification of higher density P . ovalecurtisi or P . ovalewallikeri infections that are amenable to downstream next-generation sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Department of Epidemiology, School of Public Health, Guangdong Provincial Key Laboratory of Tropical Disease Research, Southern Medical University, Guangzhou, China.
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
- Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
- SANRU Asbl, Kinshasa, Democratic Republic of the Congo.
- Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
ORCID-Profile: Jonathan B Parr
Förderung
- NIAID NIH HHS
- US National Institutes of Health
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- Global Fund to Fight AIDS, Tuberculosis, and Malaria
Zitieren
APA
He, W., Sendor, R., Potlapalli, V. R., Kashamuka, M. M., Tshefu, A. K., Phanzu, F., Kalonji, A., Ngasala, B., Thwai, K. L., Juliano, J. J., Lin, J. T., & Parr, J. B. (2024). Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011759
Vancouver
He W, Sendor R, Potlapalli VR, Kashamuka MM, Tshefu AK, Phanzu F, et al. Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0011759
BibTeX
@article{He2024,
author = {He, Wenqiao and Sendor, Rachel and Potlapalli, Varun R and Kashamuka, Melchior M and Tshefu, Antoinette K and Phanzu, Fernandine and Kalonji, Albert and Ngasala, Billy and Thwai, Kyaw Lay and Juliano, Jonathan J and Lin, Jessica T and Parr, Jonathan B},
title = {Development of new real-time PCR assays for detection and species differentiation of Plasmodium ovale},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0011759}
}
EUVIMED